Skip to main content

Amgen Inc

AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000318154

In the last 90 days, Amgen Inc insiders filed 0 open-market purchases and 3 sales; 3,168 institutions reported holding it in 13F filings for Q2 2026, worth $161.8B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Amgen Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
3 insiders, $4.11M in total
Insiders trading
3
Net value
−$4.11M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Amgen Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Amgen Inc
NameTitleLast reported holdingLast filingFilings, past year
Khosla RachnaSVP, Business Development6,404Aug 13, 20268
Busch Matthew C.VP, Finance & CAO5,080Aug 12, 20268
Ishrak OmarDirector7,486Aug 10, 20264
Holley Charles MDirector12,990Aug 10, 20264
Drake Michael VDirector5,876Aug 10, 20264
Miller DerekSVP, Human Resources12,462Aug 7, 20266
Grygiel Nancy A.SVP & CCO7,340Aug 7, 20267
Eckert RobertDirector26,251May 21, 20261
Miles Amy EDirector5,640May 21, 20261
Kullman Ellen JamisonDirector14,536May 21, 20261
Jacks TylerDirector18,284May 21, 20261
Garland Greg C.Director13,848May 21, 20261
Austin Wanda MDirector8,018May 21, 20261
Druker BrianDirector8,391May 21, 20261
Klotman Mary E.Director2,211May 21, 20261
Graham Jonathan PEVP & Gen. Counsel & Sec.39,712May 11, 20265
Bradway Robert AChairman, CEO and President505,160May 11, 20266
Gordon MurdoEVP, Global Commercial Ops51,222May 11, 20266
Santos EstebanEVP, Operations82,847May 11, 20266
Reese David MEVP & Chief Technology Officer42,256May 11, 20266
Griffith Peter H.EVP & CFO50,150May 11, 20265
Bradner James E.EVP, Research and Development30,016May 11, 20263
Sugar Ronald DDirector19,682May 23, 20230
Williams R SandersDirector6,240May 23, 20230
Louie Linda H.VP, Finance & CAO9,966May 9, 20230
Johnston Lori AEVP, HR40,881Mar 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 13, 2026 (view filing)7:05 PM ETAug 11-132 daysKhosla RachnaSVP, Business DevelopmentSSale−3.25K$414.05−$1.35M−33.7%6.40K after2 lots
Aug 7, 2026 (view filing)6:47 PM ETAug 61 dayMiller DerekSVP, Human ResourcesSSale−3.89K$402.54−$1.57M−23.8%12.5K after2 lots
Aug 7, 2026 (view filing)6:45 PM ETAug 61 dayGrygiel Nancy A.SVP & CCOSSale−2.97K$402.16−$1.19M−28.8%7.34K after2 lots
May 5, 2026 (view filing)May 41 dayGrygiel Nancy A.SVP & CCOSSale−1.24K$323.73−$400.5K−15.0%7.01K after
Mar 2, 2026 (view filing)Feb 264 daysSantos EstebanEVP, OperationsSSale−54.8K$379.12−$20.8M−41.7%76.6K after2 lots
Feb 20, 2026 (view filing)Feb 191 dayBusch Matthew C.VP, Finance & CAOSSale−1.00K$375.79−$375.8K−22.6%3.42K after
Nov 21, 2025 (view filing)Nov 201 dayGrygiel Nancy A.SVP & CCOSSale−3.14K$337.26−$1.06M−30.3%7.22K after2 lots
Nov 13, 2025 (view filing)Nov 121 dayKhosla RachnaSVP, Business DevelopmentSSale−890$336.24−$299.3K−11.2%7.08K after
Nov 13, 2025 (view filing)Nov 121 dayGordon MurdoEVP, Global Commercial OpsSSale−6.88K$336.83−$2.32M−14.1%41.9K after
Aug 22, 2025 (view filing)Aug 202 daysGrygiel Nancy A.SVP & CCOSSale−1.27K$296.99−$376.3K−14.9%7.21K after
Jun 6, 2025 (view filing)Jun 51 dayKhosla RachnaSVP, Business DevelopmentSSale−1.50K$289.68−$434.5K−15.5%8.16K after
May 6, 2025 (view filing)May 24 daysBusch Matthew C.VP, Finance & CAOSSale−1.00K$279.69−$279.7K−19.9%4.03K after
Feb 21, 2025 (view filing)Feb 192 daysSantos EstebanEVP, OperationsSSale−8.71K$292.84−$2.55M−10.9%71.5K after
Feb 21, 2025 (view filing)Feb 19-212 daysReese David MEVP & Chief Technology OfficerSSale−33.9K$301.56−$10.2M−47.9%36.9K after2 lots
Feb 20, 2025 (view filing)Feb 18-192 daysMiller DerekSVP, Human ResourcesSSale−2.02K$293.45−$593.9K−19.2%8.54K after2 lots
Feb 13, 2025 (view filing)Feb 112 daysGordon MurdoEVP, Global Commercial OpsSSale−8.77K$294.79−$2.59M−16.6%44.2K after
Feb 10, 2025 (view filing)Feb 73 daysGraham Jonathan PEVP & Gen. Counsel & Secy.SSale−25.0K$293.12−$7.34M−46.4%29.0K after
Feb 6, 2025 (view filing)Feb 51 dayGrygiel Nancy A.SVP & CCOSSale−1.59K$304.47−$483.8K−18.1%7.21K after
May 3, 2024 (view filing)May 3Same dayGrygiel Nancy A.SVP & CCOSSale−2.12K$313.09−$662.8K−17.6%9.88K after
Dec 4, 2023 (view filing)Dec 4Same dayGrygiel Nancy A.SVP & CCOSSale−2.10K$273.03−$572.3K−16.2%10.9K after
Nov 13, 2023 (view filing)Nov 85 daysGraham Jonathan PEVP, Gen. Counsel & Secy.SSale−10.0K$272.81−$2.73M−26.3%28.1K after
Aug 11, 2023 (view filing)Aug 101 dayGordon MurdoEVP, Global Commercial OpsSSale−9.56K$262.43−$2.51M−17.7%44.3K after
Nov 10, 2022 (view filing)Nov 91 dayKhosla RachnaSVP, Business DevelopmentSSale−387$292.90−$113.4K−5.5%6.63K after
Nov 8, 2022 (view filing)Nov 8Same dayGrygiel Nancy A.SVP & CCOSSale−545$293.54−$160.0K−4.0%13.0K after
Aug 22, 2022 (view filing)Aug 22Same dayWilliams R SandersDirectorSSale−200$249.96−$50.0K−3.6%5.30K after
Aug 19, 2022 (view filing)Aug 181 dayEckert RobertDirectorSSale−6.60K$249.00−$1.64M−23.8%21.2K after
May 23, 2022 (view filing)May 23Same dayWilliams R SandersDirectorSSale−600$250.00−$150.0K−9.8%5.50K after
May 10, 2022 (view filing)May 10Same dayGraham Jonathan PEVP, Gen. Counsel & Secy.SSale−13.5K$241.81−$3.26M−26.6%37.3K after